课题基金 / 基金详情

项目摘要

项目成果

JONATHAN H FREEDMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Currently, there are over 80,000 chemicals in use and approximately 2000 new chemicals are introduced into use every year. Regulatory agencies have recognized the need for alternative toxicological methods and models to decrease the time and expense of current toxicity testing protocols. In association with the National Toxicology Program (NTP), our group is developing C. elegans as an alterative organism for in vivo toxicological testing. Short life cycles, easy and inexpensive maintenance and culturing, and detailed biological knowledge has allowed for the development of rapid, low-cost toxicity tests that readily lend themselves to mechanistic studies of toxicant actions. Because of the evolutionarily conserved nature of the stress-response and other relevant pathways, it is likely that responses elicited in C. elegans will be applicable to understanding similar processes in higher organisms, including humans. This group is part of the National Toxicology Program and within the new Biomolecular Screening Branch. The screening core is involved in the development of C. elegans as an alternative organism for toxicological testing. Because of the evolutionarily conserved nature of signal transduction and stress-response pathways, it is likely that responses elicited in C. elegans will be applicable to understanding similar processes in higher organisms. There are two major activities of this group: research and development of C. elegans MTS and HTS technologies and participation in the MOU among the NTP, EPA, and NCGC, designated Tox21 (Science 15 February 2008 319: 906-907 DOI: 10.1126/science.1154619). 1. Development of C. elegans medium-throughput screening assays - Protocols for the monitoring of growth, size, reproduction, feeding, and movement have been developed and have been used to test 100 toxicants. Included in the creation of monitoring protocols, statistical analysis routines have been developed specifically for the C. elegans data. We have submitted one manuscript on the feeding assay and are completing additional studies that will be included in manuscripts currently being prepared on the reproduction and growth assays. In collaboration with Chris Portier (LMT), Grace Kissling (EDBP), Marjolein Smith (ASI) we have developed a mathematical model that described C. elegans growth and the effects of toxicants on growth parameters. We are currently generating a collection of green fluorescent protein-based, stress-responsive transgenic C. elegans lines. These lines of C. elegans will be used to identify the ability of toxicants to modulate the activities of signaling and stress-responsive pathways know the affect organism development (e.g., MAPK, p53, tyrosine phosphatase). 2. National Toxicology Program HTS faculty - I am participating in the NTP/EPA/NCGC MOU. We have begun developing protocols to use C. elegans as an HTS test organism. This includes the development of new sampling formats, statistical tools and QA/QC protocols. We are currently testing the NTP 1408 and the ToxCast 320 pesticide actives chemical sets.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.yexcr.2014.01.013
发表时间: 2014-03-10
期刊: Experimental cell research
影响因子: 3.7
作者: [Song MO, Mattie MD, Lee CH, Freedman JH]
通讯作者: Freedman JH
DOI: 10.1371/journal.pone.0001259
发表时间: 2007-12-05
期刊: PloS one
影响因子: 3.7
作者: [Boyd WA, McBride SJ, Freedman JH]
通讯作者: Freedman JH
Core--Functional Genomics
  • 批准号:
    6900510
  • 项目类别:
  • 资助金额:
    $38.04万
  • 财政年份:
    2005
  • 负责人:
    JONATHAN H FREEDMAN
  • 依托单位:
Mechanism of Stress-Induced Developmental Abnormalities
  • 批准号:
    6900498
  • 项目类别:
  • 资助金额:
    $23.09万
  • 财政年份:
    2005
  • 负责人:
    JONATHAN H FREEDMAN
  • 依托单位:
Mechanism of stress induced developmental abnormalities
  • 批准号:
    6664588
  • 项目类别:
  • 资助金额:
    $8.64万
  • 财政年份:
    2002
  • 负责人:
    JONATHAN H FREEDMAN
  • 依托单位:
Mechanism of stress induced developmental abnormalities
  • 批准号:
    6577242
  • 项目类别:
  • 资助金额:
    $8.64万
  • 财政年份:
    2002
  • 负责人:
    JONATHAN H FREEDMAN
  • 依托单位:
海外基金